Rajesh Narwal,Paul Robbins,Joyson Karakunnel,Mohammed M Dar
申请号：
GB201508097
公开号：
GB2531094A
申请日:
2015.05.12
申请国别(地区):
GB
年份:
2016
代理人:
摘要：
Methods of treating cancer, specifically non-small cell lung cancers (NSCLC), comprising administering MEDI4736 (a PD-L1 monoclonal antibody) or an antigen-binding fragment at a dosage between 1 mg/kg 20 mg/kg and tremelimumab (a CTLA-4 monoclonal antibody) or an antigen-binding fragment at a dosage between 1 mg/kg 10 mg/kg.
